About (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide
(E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide (PubChem CID 20580982) has the molecular formula C23H31ClN4O5S2
and a molecular weight of 543.11 g/mol. Its IUPAC name is (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide.
Molecular Properties
| Compound Name | (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide |
| PubChem CID | 20580982 |
| Molecular Formula | C23H31ClN4O5S2 |
| Molecular Weight | 543.11 g/mol |
| Exact Mass | 542.14 |
| IUPAC Name | (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide |
| SMILES | O=C1C(NS(=O)(=O)/C=C/c2ccc(Cl)s2)CCCN1CC(=O)N1CC2CC2C1CN1CCOCC1 |
| InChI | InChI=1S/C23H31ClN4O5S2/c24-21-4-3-17(34-21)5-11-35(31,32)25-19-2-1-6-27(23(19)30)15-22(29)28-13-16-12-18(16)20(28)14-26-7-9-33-10-8-26/h3-5,11,16,18-20,25H,1-2,6-10,12-15H2/b11-5+ |
| InChIKey | BUHUFBDMODAYPN-VZUCSPMQSA-N |
| XLogP | 1.46 |
| TPSA | 99.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 543.11 |
| LogP ≤ 5 | 1.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide?
The IUPAC name of (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide (CID 20580982) is (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide.
What is the SMILES notation for (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide?
The canonical SMILES for (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide is O=C1C(NS(=O)(=O)/C=C/c2ccc(Cl)s2)CCCN1CC(=O)N1CC2CC2C1CN1CCOCC1.
What is the InChIKey of (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide?
The InChIKey is BUHUFBDMODAYPN-VZUCSPMQSA-N. The full InChI is InChI=1S/C23H31ClN4O5S2/c24-21-4-3-17(34-21)5-11-35(31,32)25-19-2-1-6-27(23(19)30)15-22(29)28-13-16-12-18(16)20(28)14-26-7-9-33-10-8-26/h3-5,11,16,18-20,25H,1-2,6-10,12-15H2/b11-5+.
What are the key properties of (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide?
(E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide has a molecular weight of 543.11 g/mol, XLogP of 1.46, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-2-(5-chlorothiophen-2-yl)-N-[1-[2-[2-(morpholin-4-ylmethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-oxoethyl]-2-oxopiperidin-3-yl]ethenesulfonamide is sourced from PubChem (CID 20580982), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).